A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Clinical trial NCT01325441 · COMPLETED
Trial details
- NCT number
- NCT01325441
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2021-06-01
- Enrollment
- 565
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.